PubMed · 2008 · 243 citations · 19 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryCell TherapyElbow SurgeryOrthopedicsCartilage RegenerationIntra-articular TherapyJoint DiseaseJoint SurgeryMesenchymal Stem Cell TherapyOsteoarthritisAdipose-derived Mesenchymal Stem CellsAdipose-derived Mesenchymal Stromal CellsCanine OsteoarthritisOutcome Measures
Autologous adipose-derived mesenchymal stem cell (AD-MSC) therapy involves harvesting fat from the patient, isolating the stem and regenerative cells, and administering the cells back to the patient. Autologous AD-MSC therapy in veterinary regenerative medicine has been commercially available since 2003. Previously reported results from a blinded, controlled trial in dogs with chronic osteoarthritis of the coxofemoral (hip) joint demonstrated efficacy of a single intraarticular injection of autologous AD-MSC therapy. The primary objective of the current study was to evaluate the effectiveness of this therapy in dogs with chronic osteoarthritis of the humeroradial (elbow) joints and to determine the duration of effect. Fourteen dogs were recruited. Veterinarians assessed each dog for lameness, pain on manipulation, range of motion, and functional disability using a numeric rating scale at baseline and specified intervals up to 180 days after treatment. Statistically significant improvement in outcome measures was demonstrated.
19
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Patricia A. Zuk, Min Zhu, Hiroshi Mizuno et al. · Tissue Engineering · 2001 · 8K citations
Stem cell therapy in a caprine model of osteoarthritis
Mary Murphy, David J. Fink, Ernst B. Hunziker et al. · Arthritis & Rheumatism · 2003 · 1.1K citations
Luis A. Ortiz, Maria Dutreil, Cheryl L. Fattman et al. · Proceedings of the National Academy of Sciences · 2007 · 1K citations · Full text
Arthritis and Allied Conditions: A Textbook of Rheumatology.
Annals of Internal Medicine · 1991 · 767 citations